Chemical Component Summary

Name[(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid
Identifiers2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]ethanoic acid
FormulaC29 H32 O7 S
Molecular Weight524.625
TypeNON-POLYMER
Isomeric SMILESCc1cc(cc(c1c2cccc(c2)COc3ccc4c(c3)OC[C@H]4CC(=O)O)C)OCCCS(=O)(=O)C
InChIInChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
InChIKeyBZCALJIHZVNMGJ-HSZRJFAPSA-N

Chemical Details

Formal Charge0
Atom Count69
Chiral Atom Count1
Bond Count72
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB12491 
NameFasiglifam
Groups investigational
DescriptionFasiglifam has been used in trials studying the treatment of Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Diabetes Mellitus, Type 2.
SynonymsFasiglifam
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Sulfur Compounds
CAS number1000413-72-8

Related Resource References

Resource NameReference
Pharos CHEMBL1829174
PubChem 24857286
ChEMBL CHEMBL1829174
CCDC/CSD RAVXUJ